ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,892 | -80.6% | 106,544 | -78.0% | 0.03% | -76.9% |
| Q2 2023 | $14,915 | +109.2% | 485,198 | +145.2% | 0.12% | +105.1% |
| Q1 2023 | $7,131 | +13.5% | 197,915 | +24.5% | 0.06% | -35.2% |
| Q4 2022 | $6,282 | -97.8% | 158,964 | +2155.8% | 0.09% | +2175.0% |
| Q3 2022 | $283,000 | -92.2% | 7,047 | -92.5% | 0.00% | -91.3% |
| Q1 2022 | $3,642,000 | -16.0% | 93,492 | -11.6% | 0.05% | -4.2% |
| Q2 2021 | $4,334,000 | +498.6% | 105,724 | +537.0% | 0.05% | +336.4% |
| Q1 2021 | $724,000 | -92.7% | 16,596 | -92.9% | 0.01% | -94.4% |
| Q3 2020 | $9,852,000 | +795.6% | 234,190 | +933.8% | 0.20% | +575.9% |
| Q2 2020 | $1,100,000 | – | 22,654 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |